Peraso Announces Closing of $4.172 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
This is a paid press release. Contact the press release distributor directly with any inquiries.

Peraso Announces Closing of $4.172 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option

ACCESS Newswire · Peraso, Inc.

SAN JOSE, CA / ACCESSWIRE / February 8, 2024 / Peraso Inc. (NASDAQ:PRSO) ("Peraso" or the "Company"), a leader in mmWave technology, today announced the closing of its previously announced underwritten public offering of common stock, pre-funded warrants, Series A warrants and Series B warrants for gross proceeds of approximately $4.172 million, prior to deducting underwriting discounts and commissions and offering expenses. The offering proceeds include partial exercise of the underwriter's over-allotment option to purchase additional shares of common stock, Series A warrants and Series B warrants (the "Offering").

Ladenburg Thalmann & Co. Inc. acted as the sole book-running manager for the Offering.

The Offering consisted of a total of 562,500 shares of common stock, pre-funded warrants to purchase up to 1,424,760 shares of common stock, Series A warrants to purchase up to 3,974,520 shares of common stock and Series B warrants to purchase up to 3,974,520 shares of common stock. The securities issued at closing included 82,500 shares of common stock, Series A warrants to purchase up to 165,000 shares of common stock and Series B warrants to purchase up to 165,000 shares of common stock, which securities were issued upon the partial exercise of the underwriter's over-allotment option.

Each share of common stock and each pre-funded warrant was sold together with two Series A warrants to purchase one share of common stock each and two Series B warrants to purchase one share of common stock each. The Series A warrants have an exercise price of $2.25 per share, are exercisable immediately upon issuance, and expire five years following the date of issuance. The Series B warrants have an exercise price of $2.25 per share, are exercisable immediately upon issuance, and expire six months following the date of issuance. The pre-funded warrants are immediately exercisable at a nominal exercise price of $0.001 per share and may be exercised at any time until all of the pre-funded warrants are exercised in full. The warrants are fixed priced and do not contain any price based anti-dilution or variable pricing features. The combined public offering price of each share of common stock, together with the accompanying Series A warrants and Series B warrants, was $2.10, less underwriting discounts and commissions. The combined public offering price of each pre-funded warrant, together with the accompanying Series A warrants and Series B warrants, was $2.099, less underwriting discounts and commissions. Peraso currently intends to use the net proceeds of the Offering to fund operations and for working capital and other general corporate purposes.